77 /100
CRITICAL RISK
Score updated May 29, 2026

HCWB — HCW Biologics Inc. Dilution Risk Tracker

Track HCWB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HCWB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
40
⚠️ Warrant Exposure
70
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
68%
💰 Capital Raise 75%
• Critical: only 1.3 months cash remaining
• Active shelf registration ($6M, 37% of market cap)
🔄 Reverse Split 70%
• 50-day avg $0.70 below $1 exchange minimum
• Only 1 months cash — financial pressure
📜 Warrant Exercise 50%
• Massive warrant overhang: 35% of shares outstanding
• Elevated warrant risk score (70/100)
🔔 Track HCWB — Get forecast alerts →

💹 Market Data

Market Cap$14.97M
Shares Outstanding7.16M
Float6.15M
Cash$1.23M
Debt$6.58M
Short InterestN/A

🏛 Institutional Holdings

10 institutional holders · 717.3K shares
#1 Armistice Capital, LLC 300.2K shares
#2 HRT Financial LP 266.4K shares
#3 Virtu Financial LLC 47.8K shares
+ 7 more holders Sign up free to view →

📉 Short Interest

Short Interest570.9K
Days to Cover1.0
% of Float9.3%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Jun 30, 2025
EFFECT EFFECT Apr 29, 2026
S-1/A SHELF Apr 24, 2026
S-1 SHELF Apr 23, 2026
Full SEC filing analysis available with free account

📰 Recent News

Track HCWB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HCWB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for HCWB
📊 HCWB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HCWB Signal Convergence & Dark Pool Activity — StonkWhisper 📄 HCWB Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.